35results about How to "Counteract side effects" patented technology

Disclosed herein is a pharmaceutical composition, containing a thiazide compound and an angiotensin-II-receptor blocker, and a technology for formulating the same. More particularly, disclosed is a pharmaceutical combination formulation of thiazide compound and angiotensin-II-receptor blocker, which maximizes the pharmacological and clinical antihypertensive effects and complication preventive effects of the drugs and reduces the side effects of the drugs, compared to when single-component formulations of the drugs are administered simultaneously.

The method of exhausting and in-situ hydrothermally synthesizing type-A molecular sieve film includes: pumping with water pump or compressing with compressor to make the crystal kernel formed in the synthetic liquid migrate fast to the surface of the base film to speed the synthesis of type-A molecular sieve film, with the pumping or compressing pressure being 0.0005-0.0500 MPa and the pumping or compressing time being 10-500 min; and hydrothermally synthesizing type-A molecular sieve film in the solution comprising Na2O in 20-100 portions, Al2O3 in 0.5-5 portions, SiO2 in 5 portions and H2O in 500-4000 portions at 323-373 K for 1-60 hr. The present invention has obviously reduced molecular sieve film synthesizing time and raised material utilization, and the synthesized molecular sieve film is homogeneous, compact and continuous.

A method for administering an active pharmaceutical agent (APA) is provided that includes the steps of: a) providing a medicine having a dose of at least one APA and at least one active botanical agent (ABA) or dietary supplement; and b) dosing the APA within the medicine such that within each subsequent dose of the medicine, the amount of the APA decreases and the amount of the ABA increases, or remains the same, or decreases relative to an earlier amount. A trace of the APA may or may not remain in the pill toward the end of medicine application.

The present invention relates to an oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w / w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w / w based on total dry matter.

The invention discloses a composition and a preparation method thereof, a preparation and a use. The composition comprises, by weight, 29.5% to 30.5% of horseradish tree leaf ultrafine powder, 29.5% to 30.5% of cassia seed extract, 14.5% to 15.5% of fructus cannabis powder, 12.5% to 13.5% of refined fructus phyllanthi powder, 6.5% to 7.5% of lotus leaf powder and 4.5% to 5.5% of aloe ultrafine powder. The composition has obvious effects of removing toxins, relaxing bowels, supplying calcium, clearing away heat, lubricating intestines, improving liver, improving eyesight, treating constipation, improving immunity, strengthening and protecting liver and accelerating metabolism.

The invention discloses a preparation method of haw jelly, which comprises the steps that: (1) fresh haw fruits without diseases and pests are selected, cleaned by water and dried in the shade; (2) tuckahoe is selected, crushed and filtered in a 200-mesh sieve; (3) raw materials are mixed by the ratio that: 20 portions to 30 portions of water, 25 portions to 30 portions of white sugar, 40 portions to 50 portions of haw, 5 portions to 8 portions of tuckahoe and 1 portion to 2 portions of alum, and put into a boiler to be boiled for 5 minutes to 10 minutes until the pulp is smashed; (4) the mixture continues to be cooked for 20 minutes to 30 minutes while being stirred; and (5) after being cooked, the mixture is naturally cooled to room temperature, condensed into blocks, cut into slips or blocks according to processing or packaging needs, and then packaged. The raw materials of the preparation method of haw jelly are haw and tuckahoe, and the prepared haw jelly not only has the therapeutic value of removing food retention, eliminating indigestion and absorbing clots of haw but also has the medical value of clearing damp and promoting diuresis, tonifying the spleen and stomach, and relieving mental stress of tuckahoe, effectively offsets the side effect of the haw to the stomach, and plays complementary roles.

The invention discloses a skin care product containing Periplaneta americana extract suitable for the skin of diabetic patients, which belongs to the technical field of cosmetics. The active ingredients of the skin care product protected by the present invention are the extract of Periplaneta americana, the extract of Pachyphyllum yunnanensis and the auxiliary materials used in daily cosmetics and skin care products. The active ingredients of the present invention, Periplaneta americana and P. diatriana, as active ingredients for beauty and moisturizing, have a remarkable effect on the skin of diabetic patients. In particular, the addition of the active ingredients of P. americana extract makes the synergistic effect of the extract of Periplaneta americana and the matrix It has better transdermal absorption, stronger antibacterial effect, and better skin repair effect. It has a very good curative effect on pigmented sunken scars on the skin of diabetic patients, and largely relieves the single or excessive use of Periplaneta americana. , causing side effects of skin wound scars, and has a good application prospect.